This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Global Pain Management Devices Industry

5. SELECT PAIN MANAGEMENT DEVICE APPROVALS II-29Myoscience Obtains FDA Approval for New Pain Management Device II-29Nevro Obtains FDA Approval to Start SENZA-RCT Clinical Trial II-29Medasys Obtains PMA Approval from FDA for Prometra® II-29Boston Scientific Obtains CE Mark Approval for Infinion™16Percutaneous Lead II-30Boston Scientific Obtains FDA Approval for Infinion™16Percutaneous Lead II-30Medtronic Receives FDA Approval for New NeurostimulationSystem II-30St. Jude Medical Obtains FDA Approval for EpiducerNeurostimulation Delivery System II-31St. Jude Medical Receives European CE Mark Approval for Penta™Surgical Lead II-31Wellness Pro 2010 ® Micro Current Frequency Generator ReceivesFDA Approval II-31

6. PRODUCT INNOVATIONS/INTRODUCTIONS II-32Bio-Medical Research Introduces Neurotech Recovery Device II-32DJO Global Unveils OA Nano™ Knee Brace II-32Smiths Medical Unveils CADD®-Solis System with PIB II-32DJO Global Introduces Empi Active™ Knee Transcutaneous TENSSystem II-32Boston Scientific Introduces D4 and W4 Spinal Cord StimulationLead Splitters II-33Competitive Technologies Commercially Launches Calmare® II-33

7. RECENT INDUSTRY ACTIVITY II-34Kimberly-Clark Takes Over Pain Management Division of BaylisMedical II-34Competitive Technologies and Calmare® Scrambler Therapy®Extend Agreement II-34Amerinet Signs Agreement with MMJ Labs II-34Meridian Health System Forms Joint Mobile Health Venture withCypak II-34St Jude Medical Inks Agreement with Greatbatch Medical II-35NeuroTherm Acquires Smith & Nephew's Interventional Spine PainManagement Assets II-35

8. FOCUS ON SELECT PLAYERS II-36Boston Scientific Corporation (US) II-36Codman & Shurtleff, Inc. (US) II-36DJO Global, Inc. (US) II-37Kimberly-Clark Corporation (US) II-37Bio-Medical Research (BMR) Ltd. ( Ireland) II-38Medtronic, Inc. (US) II-38NeuroTherm® (US) II-39Smiths Medical (UK) II-39St. Jude Medical, Inc. (US) II-40Stryker Corporation (US) II-41

9. GLOBAL MARKET PERSPECTIVE II-43Table 6: World Recent Past, Current & Future Analysis for PainManagement Devices by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Restof World Markets Independently Analyzed with Annual RevenueFigures in US$ Million for Years 2010 through 2018 (includescorresponding Graph/Chart) II-43

Table 7: World Historic Review for Pain Management Devices byGeographic Region - US, Canada, Japan, Europe, Asia-Pacific(excluding Japan), Latin America and Rest of World MarketsIndependently Analyzed with Annual Revenue Figures in US$Million for Years 2004 through 2009 (includes correspondingGraph/Chart) II-44

Table 8: World 15-Year Perspective for Pain Management Devicesby Geographic Region - Percentage Breakdown of Annual Revenuefor US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years2004, 2012 & 2018 (includes corresponding Graph/Chart) II-45


3 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%
YHOO $36.60 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs